β2-Agonist clenbuterol suppresses bacterial phagocytosis of splenic macrophages expressing high levels of macrophage receptor with collagenous structure

Ken Shirato, Shogo Sato, Madoka Sato, Yoko Hashizume, Kaoru Tachiyashiki, Kazuhiko Imaizumi

    Research output: Contribution to journalArticle

    4 Citations (Scopus)

    Abstract

    Splenic marginal zone macrophages expressing macrophage receptor with collagenous structure (MARCO) contribute to the clearance of blood-borne pathogens. We determined a splenic adherent cell fraction abundantly containing cells expressing a higher level of MARCO by flow cytometry, and examined the effects of daily administration of an anabolic dose of β2-agonist clenbuterol on the phagocytic capacity of the cells in mice. After 6 weeks of clenbuterol (1.0 mg/kg body weight/d) or vehicle administration to the mice, splenic adherent cells were isolated. These cells were separated into three cell-size subpopulations. Among them, the small-cell subpopulation contained abundantly the cells with markedly higher levels of MARCO and exhibited more intense phagocytic capacity against Escherichia coli, as compared with the other subpopulations. The phagocytic capacity of the small cells was significantly reduced after clenbuterol administration. These results suggest that the utilization of clenbuterol as doping drug impairs bacterial clearance in the spleen.

    Original languageEnglish
    Pages (from-to)475-480
    Number of pages6
    JournalBiological and Pharmaceutical Bulletin
    Volume36
    Issue number3
    DOIs
    Publication statusPublished - 2013 Mar

    Fingerprint

    Clenbuterol
    Phagocytosis
    Macrophages
    Blood-Borne Pathogens
    Phagocytes
    Cell Size
    Flow Cytometry
    Spleen
    Body Weight
    Escherichia coli

    Keywords

    • β2-agonist
    • Doping
    • Macrophage receptor with collagenous structure
    • Phagocytosis
    • Splenic macrophage

    ASJC Scopus subject areas

    • Pharmaceutical Science
    • Pharmacology

    Cite this

    β2-Agonist clenbuterol suppresses bacterial phagocytosis of splenic macrophages expressing high levels of macrophage receptor with collagenous structure. / Shirato, Ken; Sato, Shogo; Sato, Madoka; Hashizume, Yoko; Tachiyashiki, Kaoru; Imaizumi, Kazuhiko.

    In: Biological and Pharmaceutical Bulletin, Vol. 36, No. 3, 03.2013, p. 475-480.

    Research output: Contribution to journalArticle

    Shirato, Ken ; Sato, Shogo ; Sato, Madoka ; Hashizume, Yoko ; Tachiyashiki, Kaoru ; Imaizumi, Kazuhiko. / β2-Agonist clenbuterol suppresses bacterial phagocytosis of splenic macrophages expressing high levels of macrophage receptor with collagenous structure. In: Biological and Pharmaceutical Bulletin. 2013 ; Vol. 36, No. 3. pp. 475-480.
    @article{1eafffd0fe33464ea09aff413997570c,
    title = "β2-Agonist clenbuterol suppresses bacterial phagocytosis of splenic macrophages expressing high levels of macrophage receptor with collagenous structure",
    abstract = "Splenic marginal zone macrophages expressing macrophage receptor with collagenous structure (MARCO) contribute to the clearance of blood-borne pathogens. We determined a splenic adherent cell fraction abundantly containing cells expressing a higher level of MARCO by flow cytometry, and examined the effects of daily administration of an anabolic dose of β2-agonist clenbuterol on the phagocytic capacity of the cells in mice. After 6 weeks of clenbuterol (1.0 mg/kg body weight/d) or vehicle administration to the mice, splenic adherent cells were isolated. These cells were separated into three cell-size subpopulations. Among them, the small-cell subpopulation contained abundantly the cells with markedly higher levels of MARCO and exhibited more intense phagocytic capacity against Escherichia coli, as compared with the other subpopulations. The phagocytic capacity of the small cells was significantly reduced after clenbuterol administration. These results suggest that the utilization of clenbuterol as doping drug impairs bacterial clearance in the spleen.",
    keywords = "β2-agonist, Doping, Macrophage receptor with collagenous structure, Phagocytosis, Splenic macrophage",
    author = "Ken Shirato and Shogo Sato and Madoka Sato and Yoko Hashizume and Kaoru Tachiyashiki and Kazuhiko Imaizumi",
    year = "2013",
    month = "3",
    doi = "10.1248/bpb.b12-00875",
    language = "English",
    volume = "36",
    pages = "475--480",
    journal = "Biological and Pharmaceutical Bulletin",
    issn = "0918-6158",
    publisher = "Pharmaceutical Society of Japan",
    number = "3",

    }

    TY - JOUR

    T1 - β2-Agonist clenbuterol suppresses bacterial phagocytosis of splenic macrophages expressing high levels of macrophage receptor with collagenous structure

    AU - Shirato, Ken

    AU - Sato, Shogo

    AU - Sato, Madoka

    AU - Hashizume, Yoko

    AU - Tachiyashiki, Kaoru

    AU - Imaizumi, Kazuhiko

    PY - 2013/3

    Y1 - 2013/3

    N2 - Splenic marginal zone macrophages expressing macrophage receptor with collagenous structure (MARCO) contribute to the clearance of blood-borne pathogens. We determined a splenic adherent cell fraction abundantly containing cells expressing a higher level of MARCO by flow cytometry, and examined the effects of daily administration of an anabolic dose of β2-agonist clenbuterol on the phagocytic capacity of the cells in mice. After 6 weeks of clenbuterol (1.0 mg/kg body weight/d) or vehicle administration to the mice, splenic adherent cells were isolated. These cells were separated into three cell-size subpopulations. Among them, the small-cell subpopulation contained abundantly the cells with markedly higher levels of MARCO and exhibited more intense phagocytic capacity against Escherichia coli, as compared with the other subpopulations. The phagocytic capacity of the small cells was significantly reduced after clenbuterol administration. These results suggest that the utilization of clenbuterol as doping drug impairs bacterial clearance in the spleen.

    AB - Splenic marginal zone macrophages expressing macrophage receptor with collagenous structure (MARCO) contribute to the clearance of blood-borne pathogens. We determined a splenic adherent cell fraction abundantly containing cells expressing a higher level of MARCO by flow cytometry, and examined the effects of daily administration of an anabolic dose of β2-agonist clenbuterol on the phagocytic capacity of the cells in mice. After 6 weeks of clenbuterol (1.0 mg/kg body weight/d) or vehicle administration to the mice, splenic adherent cells were isolated. These cells were separated into three cell-size subpopulations. Among them, the small-cell subpopulation contained abundantly the cells with markedly higher levels of MARCO and exhibited more intense phagocytic capacity against Escherichia coli, as compared with the other subpopulations. The phagocytic capacity of the small cells was significantly reduced after clenbuterol administration. These results suggest that the utilization of clenbuterol as doping drug impairs bacterial clearance in the spleen.

    KW - β2-agonist

    KW - Doping

    KW - Macrophage receptor with collagenous structure

    KW - Phagocytosis

    KW - Splenic macrophage

    UR - http://www.scopus.com/inward/record.url?scp=84875500771&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84875500771&partnerID=8YFLogxK

    U2 - 10.1248/bpb.b12-00875

    DO - 10.1248/bpb.b12-00875

    M3 - Article

    C2 - 23318530

    AN - SCOPUS:84875500771

    VL - 36

    SP - 475

    EP - 480

    JO - Biological and Pharmaceutical Bulletin

    JF - Biological and Pharmaceutical Bulletin

    SN - 0918-6158

    IS - 3

    ER -